Twist Bioscience
Synthetic DNA, oligo pools and NGS target enrichment products for life science researchers and biotech teams
Highlights
- New on EvolcAdded 2026-11-14
About Twist Bioscience
Twist Bioscience makes synthetic DNA using a proprietary semiconductor-based silicon platform. Its product range includes genes, oligo pools, NGS target enrichment panels and kits, antibody production and characterization, variant libraries and vectors, along with MRD panels and AI drug discovery datasets.
Customers are researchers and organizations in medicine, diagnostics, agriculture, food and industrial chemicals. Products are ordered through the company's online ordering portal and sold through channel partners and distributors. Services include custom projects such as custom antibodies and custom NGS panels.
The company is headquartered in South San Francisco, California. It states ISO 13485:2016 certification for its NGS target enrichment panels, NGS reagents and kits, and synthetic control products, and ISO 27001:2022 certification for information security. Its open roles span manufacturing, R&D, sales, marketing and corporate functions in the US and Asia-Pacific, including sites in Carlsbad, Portland, Quincy and Guangzhou.
Product: Synthetic DNA genes, oligo pools, NGS target enrichment panels and kits, antibody services and cloning vectors sold to research labs.
Jobs at Twist Bioscience
More biotech & pharma companies
TwoStep Therapeutics
Developing peptide-based targeted cancer therapies for patients with solid tumorsNew on EvolcUniversal DX
Develops blood-based early cancer detection tests for clinical and healthcare partnersNew on EvolcValo Health
AI-enabled drug discovery and development for pharmaceutical and biotech partnersNew on EvolcVaxart
Develops oral pill vaccines for infectious diseases for public health and healthcare marketsNew on EvolcVaxcyte
Clinical-stage vaccine developer making pneumococcal, Group A Strep and Shigella vaccines for children and at-risk adultsRemote-friendlyVerastem
Develops and commercializes targeted cancer therapies for patients with RAS/MAPK pathway-driven cancersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Microsoft ClarityMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Chat & support
- IntercomMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- FastlyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-served-by
- Response headerx-served-by
- Response headerx-served-by
Content management
- Adobe Experience ManagerHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- GreenhouseHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.